Skip to main content
Top
Published in: AIDS Research and Therapy 1/2022

Open Access 01-12-2022 | Care | Research

Self-transfers and factors associated with successful tracing among persons lost to follow-up from HIV care, Sheema District, Southwestern Uganda: retrospective medical records review, 2017–2021

Authors: Arnold Ssemwogerere, Javilla Kakooza Kamya, Lillian Nuwasasira, Claire Ahura, Derrick Isaac Isooba, Edith K. Wakida, Celestino Obua, Richard Migisha

Published in: AIDS Research and Therapy | Issue 1/2022

Login to get access

Abstract

Background

Due to improved coverage and scale-up of antiretroviral therapy (ART), patients are increasingly transferring between ART-providing sites. Self-transfers may constitute a high proportion of patients considered lost to follow-up (LTFU), and if overlooked when reporting patients who have dropped out of HIV care, may result in an incorrect estimation of retention. We determined the prevalence of self-transfers, and successful tracing, and identified associated factors among people living with HIV (PLHIV) LTFU from care at public health facilities in Sheema District, Southwestern Uganda.

Methods

We conducted a cross-sectional retrospective medical records review during February and March 2022. We included records of all PLHIV who were LTFU from 2017 to 2021, and who were registered at government-owned ART clinics in Sheema District. LTFU was considered for those who were not taking ART refills for a period of ≥ 3 months. We abstracted demographic and clinical data from medical records at the selected clinics. Participants were traced via phone calls or in-person to ascertain the outcomes of LTFU. We performed multivariate modified Poisson regression to identify factors associated with self-transfer, and successful tracing.

Results

Overall, 740 patients were identified as LTFU from three ART-providing clinics; of these, 560 (76%) were self-transfers. The mean age was 30 (SD ± 10) years, and most (69%, n = 514) were female; the majority (87%, 641/740) were successfully traced. Age (adjusted prevalence ratio [aPR] = 1.13, 95% CI 1.01–1.25, P = 0.026 for those aged 18–30 years compared to > 30 years), female sex (aPR = 1.18, 95% CI 1.11–1.25, P < 0.001), and having WHO clinical stage 1–2 (aPR = 2.34, 95% CI 1.89–3.91, P < 0.001) were significantly associated with self-transfer. Presence of a phone contact in the patient’s file (aPR = 1.10, 95% CI 1.01–1.90, P = 0.026) was associated with successful tracing of the patients considered LTFU.

Conclusion

Self-transfers accounted for the majority of patients recorded as LTFU, highlighting the need to account for self-transfers among patients considered LTFU, to accurately estimate retention in care. ART-providing facilities should regularly update contact information for PLHIV to enable successful tracing, in the event that the patients are LTFU. This calls for a health-tracking system that easily identifies self-transfers across ART-providing clinics using unique patient identifiers.
Literature
2.
go back to reference Uganda AIDS Commission. AIDS Country progress report July 2017–June 2018. Kampala: Uganda AIDS Commission. 2018. Uganda AIDS Commission. AIDS Country progress report July 2017–June 2018. Kampala: Uganda AIDS Commission. 2018.
3.
go back to reference World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection recommendations for a public health approach. Geneva: World Health Organization; 2016. World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection recommendations for a public health approach. Geneva: World Health Organization; 2016.
4.
go back to reference Fox MP, Rosen S. Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007–2009: systematic review. Trop Med Int Health. 2010;15:1–15.CrossRef Fox MP, Rosen S. Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007–2009: systematic review. Trop Med Int Health. 2010;15:1–15.CrossRef
5.
go back to reference Nyakato P, Kiragga AN, Kambugu A, Bradley J, Baisley K. Correction of estimates of retention in care among a cohort of HIV-positive patients in Uganda in the period before starting ART: a sampling-based approach. BMJ Open. 2018;8(4): e017487.CrossRef Nyakato P, Kiragga AN, Kambugu A, Bradley J, Baisley K. Correction of estimates of retention in care among a cohort of HIV-positive patients in Uganda in the period before starting ART: a sampling-based approach. BMJ Open. 2018;8(4): e017487.CrossRef
6.
go back to reference Fox MP, Rosen S. A new cascade of HIV care for the era of “treat all.” PLoS Med. 2017;14(4): e1002268.CrossRef Fox MP, Rosen S. A new cascade of HIV care for the era of “treat all.” PLoS Med. 2017;14(4): e1002268.CrossRef
7.
go back to reference Nglazi MD, Kaplan R, Orrell C, Myer L, Wood R, Bekker L-G, et al. Increasing transfers-out from an antiretroviral treatment service in South Africa: patient characteristics and rates of virological non-suppression. PLoS ONE. 2013;8(3): e57907.CrossRef Nglazi MD, Kaplan R, Orrell C, Myer L, Wood R, Bekker L-G, et al. Increasing transfers-out from an antiretroviral treatment service in South Africa: patient characteristics and rates of virological non-suppression. PLoS ONE. 2013;8(3): e57907.CrossRef
9.
go back to reference Optimization IAPoHCC. IAPAC for optimizing the HIV care continuum for adults and adolescents. J Int Assoc Provid AIDS Care. 2015;14(1):S3–34. Optimization IAPoHCC. IAPAC for optimizing the HIV care continuum for adults and adolescents. J Int Assoc Provid AIDS Care. 2015;14(1):S3–34.
12.
go back to reference Ministry of Health. Consolidated guidelines for the prevention and treatment of HIV and AIDS in Uganda. Kampala: Ministry of Health Kampala, Uganda; 2020. Ministry of Health. Consolidated guidelines for the prevention and treatment of HIV and AIDS in Uganda. Kampala: Ministry of Health Kampala, Uganda; 2020.
13.
go back to reference Barros AJ, Hirakata VN. Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol. 2003;3(1):1–13.CrossRef Barros AJ, Hirakata VN. Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol. 2003;3(1):1–13.CrossRef
14.
go back to reference Wilkinson LS, Skordis-Worrall J, Ajose O, Ford N. Self-transfer and mortality amongst adults lost to follow-up in ART programmes in low-and middle-income countries: systematic review and meta-analysis. Trop Med Int Health. 2015;20(3):365–79.CrossRef Wilkinson LS, Skordis-Worrall J, Ajose O, Ford N. Self-transfer and mortality amongst adults lost to follow-up in ART programmes in low-and middle-income countries: systematic review and meta-analysis. Trop Med Int Health. 2015;20(3):365–79.CrossRef
15.
go back to reference Brinkhof MW, Pujades-Rodriguez M, Egger M. Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS ONE. 2009;4(6): e5790.CrossRef Brinkhof MW, Pujades-Rodriguez M, Egger M. Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS ONE. 2009;4(6): e5790.CrossRef
16.
go back to reference Geng EH, Glidden DV, Emenyonu N, Musinguzi N, Bwana MB, Neilands TB, et al. Tracking a sample of patients lost to follow-up has a major impact on understanding determinants of survival in HIV-infected patients on antiretroviral therapy in Africa. Trop Med Int Health. 2010;15:63–9.CrossRef Geng EH, Glidden DV, Emenyonu N, Musinguzi N, Bwana MB, Neilands TB, et al. Tracking a sample of patients lost to follow-up has a major impact on understanding determinants of survival in HIV-infected patients on antiretroviral therapy in Africa. Trop Med Int Health. 2010;15:63–9.CrossRef
17.
go back to reference Dalal RP, MacPhail C, Mqhayi M, Wing J, Feldman C, Chersich MF, et al. Characteristics and outcomes of adult patients lost to follow-up at an antiretroviral treatment clinic in Johannesburg, South Africa. JAIDS J Acquired Immune Defic Syndromes. 2008;47(1):101–7.CrossRef Dalal RP, MacPhail C, Mqhayi M, Wing J, Feldman C, Chersich MF, et al. Characteristics and outcomes of adult patients lost to follow-up at an antiretroviral treatment clinic in Johannesburg, South Africa. JAIDS J Acquired Immune Defic Syndromes. 2008;47(1):101–7.CrossRef
18.
go back to reference Zakumumpa H, Bennett S, Ssengooba F. Modifications to ART service delivery models by health facilities in Uganda in promotion of intervention sustainability: a mixed methods study. Implement Sci. 2017;12(1):1–14.CrossRef Zakumumpa H, Bennett S, Ssengooba F. Modifications to ART service delivery models by health facilities in Uganda in promotion of intervention sustainability: a mixed methods study. Implement Sci. 2017;12(1):1–14.CrossRef
20.
go back to reference Brown LB, Ayieko J, Mwangwa F, Owaraganise A, Kwarisiima D, Jain V, et al. Predictors of retention in HIV care among youth (15–24) in a universal test-and-treat setting in rural Kenya. J Acquir Immune Defic Syndr. 2017;76(1):e15.CrossRef Brown LB, Ayieko J, Mwangwa F, Owaraganise A, Kwarisiima D, Jain V, et al. Predictors of retention in HIV care among youth (15–24) in a universal test-and-treat setting in rural Kenya. J Acquir Immune Defic Syndr. 2017;76(1):e15.CrossRef
21.
go back to reference Kiwanuka J, Mukulu Waila J, Muhindo Kahungu M, Kitonsa J, Kiwanuka N. Determinants of loss to follow-up among HIV positive patients receiving antiretroviral therapy in a test and treat setting: a retrospective cohort study in Masaka, Uganda. PLoS ONE. 2020;15(4): e0217606.CrossRef Kiwanuka J, Mukulu Waila J, Muhindo Kahungu M, Kitonsa J, Kiwanuka N. Determinants of loss to follow-up among HIV positive patients receiving antiretroviral therapy in a test and treat setting: a retrospective cohort study in Masaka, Uganda. PLoS ONE. 2020;15(4): e0217606.CrossRef
22.
go back to reference Govindasamy D, Ford N, Kranzer K. Risk factors, barriers and facilitators for linkage to antiretroviral therapy care: a systematic review. AIDS. 2012;26(16):2059–67.CrossRef Govindasamy D, Ford N, Kranzer K. Risk factors, barriers and facilitators for linkage to antiretroviral therapy care: a systematic review. AIDS. 2012;26(16):2059–67.CrossRef
23.
go back to reference Maskew M, MacPhail P, Menezez C, Rubel D. Lost to follow up—contributing factors and challenges in South African patients on antiretroviral therapy. S Afr Med J. 2007;97(9):853–7.PubMed Maskew M, MacPhail P, Menezez C, Rubel D. Lost to follow up—contributing factors and challenges in South African patients on antiretroviral therapy. S Afr Med J. 2007;97(9):853–7.PubMed
24.
go back to reference Weigel R, Hochgesang M, Brinkhof MW, Hosseinipour MC, Boxshall M, Mhango E, et al. Outcomes and associated risk factors of patients traced after being lost to follow-up from antiretroviral treatment in Lilongwe. Malawi BMC Infect Dis. 2011;11(1):1–8.CrossRef Weigel R, Hochgesang M, Brinkhof MW, Hosseinipour MC, Boxshall M, Mhango E, et al. Outcomes and associated risk factors of patients traced after being lost to follow-up from antiretroviral treatment in Lilongwe. Malawi BMC Infect Dis. 2011;11(1):1–8.CrossRef
25.
go back to reference Assemie MA, Leshargie CT, Petrucka P. Outcomes and factors affecting mortality and successful tracing among patients lost to follow-up from antiretroviral therapy in Pawi Hospital, Northwest Ethiopia. Trop Med Health. 2019;47(1):1–6.CrossRef Assemie MA, Leshargie CT, Petrucka P. Outcomes and factors affecting mortality and successful tracing among patients lost to follow-up from antiretroviral therapy in Pawi Hospital, Northwest Ethiopia. Trop Med Health. 2019;47(1):1–6.CrossRef
26.
go back to reference Govindasamy D, Meghij J, Negussi EK, Baggaley RC, Ford N, Kranzer K. Interventions to improve or facilitate linkage to or retention in pre-ART (HIV) care and initiation of ART in low-and middle-income settings—a systematic review. J Int AIDS Soc. 2014;17(1):19032.CrossRef Govindasamy D, Meghij J, Negussi EK, Baggaley RC, Ford N, Kranzer K. Interventions to improve or facilitate linkage to or retention in pre-ART (HIV) care and initiation of ART in low-and middle-income settings—a systematic review. J Int AIDS Soc. 2014;17(1):19032.CrossRef
Metadata
Title
Self-transfers and factors associated with successful tracing among persons lost to follow-up from HIV care, Sheema District, Southwestern Uganda: retrospective medical records review, 2017–2021
Authors
Arnold Ssemwogerere
Javilla Kakooza Kamya
Lillian Nuwasasira
Claire Ahura
Derrick Isaac Isooba
Edith K. Wakida
Celestino Obua
Richard Migisha
Publication date
01-12-2022
Publisher
BioMed Central
Published in
AIDS Research and Therapy / Issue 1/2022
Electronic ISSN: 1742-6405
DOI
https://doi.org/10.1186/s12981-022-00471-2

Other articles of this Issue 1/2022

AIDS Research and Therapy 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine